BOOKS BY CATEGORY
Your Account
Anglo-Scandinavian Cardiac Outcomes Trial
Latest Perspectives on This Landmark Trial
Price
Quantity
£14.99
(To see other currencies, click on price)
Paperback / softback
Add to basket  

MORE ABOUT THIS BOOK

Main description:

ASCOT is the largest study of hypertension ever undertaken in Europe involving >19,000 patients and also includes the study of lipid management in >10,000 patients. The results of ASCOT have had a significant impact on the prevention of coronary heart disease (CHD) and other vascular events by lowering blood pressure and reducing cholesterol. This further updated and expanded version provides clinicians with a comprehensive and detailed review of the final results of ASCOT by the steering committee of the trial. Additionally, the authors discuss implications of ASCOT for daily practice.


Contents:

Preface 1: The history of a trial 2: Hypertension trial review - ASCOT in context 3: ASCOT blood pressure-lowering arm (ASCOT-BPLA): methods, results and impact 4: ASCOT sub-studies 5: ASCOT - cardiovascular benefits in subjects with diabetes 6: New-onset diabetes and impact of glycaemia on cardiovascular events 7: Multiple risk factor intervention: evidence of benefits from ASCOT 8: Combination therapy 9: Health economic review 10: Potential synergy between CCBs and ACE inhibitors 11: Guidelines practice and future projects


PRODUCT DETAILS

ISBN-13: 9781905036158
Publisher: Sherborne Gibbs Limited
Publication date: April, 2011
Pages: 84
Dimensions: 160.00 x 240.00 x 4.00
Weight: 571g
Availability: Contact supplier
Subcategories: Cardiovascular Medicine

CUSTOMER REVIEWS

Average Rating